Study: CTE Found in 215 of 235 Donated Brains From Former NFL Players

A recent study of deceased former NFL players found that at least one in four of those who died between 2016 and 2021 had chronic traumatic encephalopathy, a condition linked to repeated head impacts. Researchers examined 878 deaths in that period and received brain donations from 235 individuals, of whom 215 tested positive for the disease. The findings come from teams at Mass General Brigham, Boston University, and the Concussion and CTE Foundation.

The condition can only be confirmed after death and has been associated with symptoms such as memory issues, mood changes, and dementia. Study lead author Daniel Daneshvar noted that repeated traumatic brain injuries contribute to higher rates of neurodegenerative disease overall. He pointed out that NFL players experience roughly four times the rate of death from such diseases compared with the general population.

An NFL statement emphasized ongoing efforts to reduce concussions through rule changes and equipment improvements. The league highlighted expanded resources for player health and encouraged former athletes to seek care when needed. Researchers also observed high rates of dementia among the donors and called for measures to limit repetitive head impacts at every level of the sport.

Many of the players who reached the NFL came from communities where athletic achievement offered one of the clearest paths to substantial earnings and status. Data on professional athlete contracts show median career lengths around three to four years, with top performers securing multimillion-dollar deals that exceed lifetime earnings available in most other fields open to individuals from similar backgrounds. These financial incentives reflect market demand from fans and media partners rather than external mandates.

Participation in contact sports remains a deliberate decision made by athletes and their families, often beginning in youth leagues. Unlike compulsory activities, football careers involve repeated assessments of personal risk against potential reward. Historical patterns in American sports show that groups facing limited options in other industries have gravitated toward fields where physical talent commands high compensation, a pattern consistent with broader observations on how individuals navigate trade-offs in open economies.

The donor pool in the study likely includes those with noticeable symptoms, which can skew observed rates upward compared with the full population of former players. Non-donors may represent cases with fewer reported issues, though precise data on that group remains unavailable. Such selection effects appear in many medical studies relying on voluntary tissue contributions.

Efforts to alter the game through additional regulations must account for the fact that players continue to enter the league aware of documented health data. Past adjustments to rules and medical protocols have already changed on-field practices, yet the core activity of high-speed collisions persists because participants and spectators value the competition. Attempts to impose uniform safety standards across all levels ignore variations in local culture, family priorities, and individual assessments of long-term consequences.

The study underscores measurable costs attached to the sport without altering the reality that those costs were weighed against tangible benefits by the athletes involved.